Status:
COMPLETED
Transcranial Magnetic Stimulation for Treatment of Methamphetamine Dependence
Lead Sponsor:
Shanghai Mental Health Center
Collaborating Sponsors:
Wuxi Mental Health Center, Jiangsu Provence, China
Suzhou Guangji Hospital, Jiangsu Provence, China
Conditions:
Methamphetamine-dependence
Eligibility:
All Genders
18-45 years
Phase:
NA
Brief Summary
Repetitive transcranial magnetic stimulation (rTMS) was used to treat methamphetamine (MA) addiction in previous studies, while the evidence-based protocols still required. The aim of this research is...
Detailed Description
First, a multicenter, double-blind, randomized control study is going to be carried out. 100 recruited patients will be randomized assigned to the intervention group and the control group, receiving e...
Eligibility Criteria
Inclusion
- In accordance with the Diagnostic and Statistical Manual of Mental Disorders-5 (DSM-5) for methamphetamine (MA) use disorders
- Junior high school degree or above
- Normal vision and hearing
- Dextromanual
- Less than one month before last drug use
Exclusion
- Have a disease that affect cognitive function such as history of head injury, cerebrovascular disease, epilepsy, etc
- Have cognitive-promoting drugs in the last 6 months
- Other substance abuse or dependence in recent five years (except nicotine)
- Mental impairment, Intelligence Quotient (IQ) \< 70
- Mental disorders
- Physical disease
Key Trial Info
Start Date :
February 1 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 12 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03827785
Start Date
February 1 2019
End Date
December 12 2020
Last Update
September 16 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shanghai Rehabilitation Center
Shanghai, China, 200010